[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-351929-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-351929-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","genetic-analysis-of-genes-gstp1-pten-and-tp53-snps-in-nonmelanoma-skin-cancer-patients","Genetic analysis of genes GSTP1, PTEN, and TP53 SNPs in nonmelanoma skin cancer patients","","Non-melanoma skin cancer (NMSC) is driven by interacting genetic, demographic, and environmental influences. A case-control study evaluated NMSC susceptibility in 300 Pakistani patients and 300 healthy controls, focusing on GSTP1 rs1695, PTEN rs701848, and TP53 rs17878362 polymorphisms, alongside age, gender, smoking status, and family history. Significant SNP–NMSC associations emerged, with genotype effects varying by sex and age. Results support these polymorphisms as candidate genetic biomarkers for early detection and risk prediction, implicating detoxification, tumor-suppressor, and DNA repair pathways.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/genetic-analysis-of-genes-gstp1-pten-and-tp53-snps-in-nonmelanoma-skin-cancer-patients/351929/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/genetic-analysis-of-genes-gstp1-pten-and-tp53-snps-in-nonmelanoma-skin-cancer-patients/351929.png","ImageObject",300,407,{"name":42,"@type":43},"Mary Man","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-06","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",7,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What genes and polymorphisms were analyzed for NMSC susceptibility?","Question",{"text":63,"@type":64},"The study examined GSTP1 rs1695, PTEN rs701848, and TP53 rs17878362 polymorphisms, relating them to NMSC risk in patients and controls.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How was the study designed and who were the participants?",{"text":68,"@type":64},"It was a case-control study including 300 Pakistani patients with NMSC and 300 healthy controls, with additional analysis of demographic factors.",{"name":70,"@type":61,"acceptedAnswer":71},"What did the results show about the association between SNPs and NMSC risk?",{"text":72,"@type":64},"All three SNPs showed significant correlations with NMSC risk, with genotype patterns differing by sex, age group, smoking status, and family history. The heterozygous and homozygous mutant genotypes were linked to higher or protective effects depending on subgroup results.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},351929,1790182362,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,110,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":107,"show_sort_weight":108,"slug":109},"Healthcare",40,"healthcare",{"id":111,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},8,30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":111,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":123,"language":139,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":12,"update_tm":143,"read_time":144,"preview_page_count":33,"preview_urls":145},7421720224475,"https://ap-avatar.wpscdn.com/davatar_276721f389ce27ea32af1340a28f341c","Journal of Cancer Research and Clinical Oncology (2026) 152:130  \n[https://doi.org/10.1007/s00432-026-06502-z](https://doi.org/10.1007/s00432-026-06502-z)  \nRESEARCH  \nGenetic analysis of genes GSTP1, PTEN, and TP53 SNPs in nonmelanoma skin cancer patients  \nYongzhong Xiong1 · Haider Ali Akhter2 · Aqsa Siddique2 · Aseel Smerat3 · Kuvonchbek Egamberdiyev4 · Ruziyeva Gulsara5 · Kashif Bashir2  \nReceived: 2 April 2026 / Accepted: 2 May 2026 © The Author(s) 2026  \nAbstract  \nBackground and objective One of the most prevalent cancers in the world, non-melanoma skin cancer (NMSC) is impacted by several genetic, demographic, and environmental factors.  \nMethodology This case-control study examined the relationship between NMSC susceptibility and GSTP1 (rs1695), PTEN (rs701848), and TP53 (rs17878362) polymorphisms in 300 Pakistani patients and 300 healthy controls. Additionally assessed were demographic factors such as age, gender, smoking status, and family history.  \nResults The findings showed a strong correlation between the risk of NMSC and all three SNPs. The heterozygous mutant genotype (AG) of GSTP1 rs1695 was significantly (p = 0.0053) associated with a higher risk of NMSC with a family history, while its heterozygote genotype (AG) was associated with smoking (p = 0.0001) . The AG genotype was associated with an increased risk of disease in males and GG showed a significant (p = 0.0010) protective association in females. The heterozygous mutant (AG) genotype in the \u003C 43 age while the homozygous mutant (GG) showed a lower disease risk (p = 0.0029) in the > 43 age group. Patients had a higher frequency of the heterozygous AG genotype (166, 55%) than controls (87, 29%) and homozygous mutant GG genotype (17, 6%) than controls (58, 19%), indicating a significant protective effect (OR = 0.25, 95% CI: 0.1–0.4; p = 0.0001) .  \nConclusion These correlations held true for age, gender, smoking status, and family history subgroups. The results indicate that these polymorphisms may function as potential genetic biomarkers for early detection and risk prediction, highlighting the crucial role of detoxification, tumor-suppressor, and DNA repair pathways inNMSC development. To confirm these findings, more extensive and useful research is advised.  \nKeywords Tumor suppressor · GSTP1 · PTEN · TP53 · Single nucleotide polymorphism (SNP) · Molecular biomarkers · Skin cancer genetics  \n􀀍 Kashif Bashir [kashifbashir70@gmail.com](kashifbashir70@gmail.com)  \n1 Department of Traditional Chinese Medicine, Pingyin People’s Hospital, Jinan City 250499, Shandong Province, China  \n2 Department of Biological Sciences, Superior University Lahore, Lahore 05400, Pakistan  \n3 Hourani Center for Applied Scientific Research, Al-Ahliyya Amman University, Amman 19328, Jordan  \n4 Department of Clinical Sciences, Mamun University, Urgench, Uzbekistan  \n5 Department of Medicine, Termez University of Economics and Service, Termez, Uzbekistan  \nIntroduction  \nThe worldwide major global problem is skin cancer, especially melanoma skin cancer (MSC) and non-melanoma skin cancer (NMSC). This form of skin cancer accounts for almost 90% of all cases. One in three cancers diagnosed worldwide is skin cancer, with NMSCs being the most common type (Urban et al. 2021). The most prevalent kind of cancer includes both MSC and NMSCs in people with fair skin (Wright and Norval 2023). Every year, about 132,000 new cases of melanoma are discovered, and there are two to three million NMSC cases globally (Huang et al. 2023). 90% ofsquamous cell carcinoma (SCC) cases and nearly 50% of basal cell carcinoma (BCC) cases involve P53 when external environmental carcinogens, such as UV radiation, damage DNA. NMSCs are produced as  \na result of this p53 protein inactivation (Loureiro 2022). BCC seldom spreads and is a locally damaging malignancy. It has follicular characteristics and begins with the epidermal layer's basal cells. A meta-analysis shows that childhood UV exposure in the highest qu","cbCaiaAJ9QSN8DHc","https://ap.wps.com/l/cbCaiaAJ9QSN8DHc","pdf",1086747,"English","# Abstract\n## Background and objective\n## Methodology\n## Results\n## Conclusion\n# Introduction","[{\"question\":\"What genes and polymorphisms were analyzed for NMSC susceptibility?\",\"answer\":\"The study examined GSTP1 rs1695, PTEN rs701848, and TP53 rs17878362 polymorphisms, relating them to NMSC risk in patients and controls.\"},{\"question\":\"How was the study designed and who were the participants?\",\"answer\":\"It was a case-control study including 300 Pakistani patients with NMSC and 300 healthy controls, with additional analysis of demographic factors.\"},{\"question\":\"What did the results show about the association between SNPs and NMSC risk?\",\"answer\":\"All three SNPs showed significant correlations with NMSC risk, with genotype patterns differing by sex, age group, smoking status, and family history. The heterozygous and homozygous mutant genotypes were linked to higher or protective effects depending on subgroup results.\"}]","Genetic analysis of genes GSTP1, PTEN, and TP53 SNPs in nonmelanoma skin cancer patients | PDF",1790096529,25,[146,150,154,158],{"page_no":22,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/746017a3af14ca9b7b374faad0e2d4bf.webp",983,1305,{"page_no":26,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/74da3545cf365ac7123ec48a50025a66.webp",982,1304,{"page_no":30,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/5246bff451bff7714a845715d48a72ab.webp",981,1303,{"page_no":33,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/78c30cd52963195591399017ac6dcba6.webp",980,1301]